August 30, 2024
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
| Attn.: |
Doris Gama Office of Life Sciences |
| Re: |
Withdrawal of Acceleration Request Virpax Pharmaceuticals, Inc. Registration Statement on Form S-1 (No. 333-281080) |
Ladies and Gentlemen:
On behalf of Virpax Pharmaceuticals, Inc. (the “Company”), this letter will serve to withdraw the request for acceleration of the above-referenced Registration Statement filed as correspondence via EDGAR on Monday, August 26, 2024.
The Company is no longer requesting that such Registration Statement be declared effective at 5:00 p.m., Eastern Time, on Monday, August 26, 2024, and we hereby formally withdraw our request for acceleration of the effective date.
Thank you for your assistance.
| Very truly yours, | |
| /s/ Ross D. Carmel | |
| Ross D. Carmel |
| cc: | Gerald W. Bruce |